Company page

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing innovative therapies for cancer treatment. The company trades under the ticker ALLO and has a market capitalization of approximately $600.6 million. Allogene is dedicated to advancing its research and development efforts in the field of allogeneic cell therapy.